History of Leukemia-lymphoma Cell Lines

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2010 Oct 27

PMID 20973832

Citations 12

Authors

Hans G Drexler

Roderick A F MacLeod

Affiliations

Soon will be listed here.

Abstract

We outline the near 50-year history of leukemia-lymphoma (LL) cell lines - a key model system in biomedicine. Due to the detailed documentation of their oncogenomic and transcriptional alterations via recent advances in molecular medicine, LL cell lines may be fitted to parent tumors with a degree of precision unattainable in other cancers. We have surveyed the corpus of published LL cell lines and found 637 examples that meet minimum standards of authentication and characterization. Alarmingly, the rate of establishment of new LL cell lines has plummeted over the last decade. Although the main hematopoietic developmental cell types are represented by cell lines, some LL categories stubbornly resist establishment in vitro. The advent of engineering techniques for immortalizing primary human cells that maintain differentiation means the time is ripe for renewed search for in vitro models from un(der)represented hematologic entities. Given their manifold applications in biomedicine, there is little doubt that LL-derived cell lines will continue to play a vital part well into the next half-century as well.

Citing Articles

Cell-TIMP: Cellular Trajectory Inference based on Morphological Parameter.

Raj P, Gupta H, Anantha P, Barman I bioRxiv. 2024; .

PMID: 38712120 PMC: 11071304. DOI: 10.1101/2024.04.18.590109.

Variable characteristics overlooked in human K-562 leukemia cell lines with a common signature.

Kasai F, Mizukoshi K, Nakamura Y Sci Rep. 2024; 14(1):9619.

PMID: 38671192 PMC: 11053119. DOI: 10.1038/s41598-024-60271-8.

CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia.

Ketzer F, Abdelrasoul H, Vogel M, Marienfeld R, Muschen M, Jumaa H Oncogenesis. 2022; 11(1):1.

PMID: 35013097 PMC: 8748974. DOI: 10.1038/s41389-021-00377-0.

Misidentified biomedical resources: Journal guidelines are not a quick fix.

Hepkema W, Horbach S, Hoek J, Halffman W Int J Cancer. 2021; 150(8):1233-1243.

PMID: 34807460 PMC: 9300184. DOI: 10.1002/ijc.33882.

Raman Microscopy: Progress in Research on Cancer Cell Sensing.

Elumalai S, Manago S, De Luca A Sensors (Basel). 2020; 20(19).

PMID: 32992464 PMC: 7582629. DOI: 10.3390/s20195525.

References

Drexler H, Fombonne S, Matsuo Y, Hu Z, Hamaguchi H, Uphoff C . p53 alterations in human leukemia-lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?. Leukemia. 2000; 14(1):198-206. DOI: 10.1038/sj.leu.2401604. View

Carrel A . ON THE PERMANENT LIFE OF TISSUES OUTSIDE OF THE ORGANISM. J Exp Med. 2009; 15(5):516-28. PMC: 2124948. DOI: 10.1084/jem.15.5.516. View

MacLeod R, Drexler H . Leukaemia cell lines are robust in vitro models. Br J Haematol. 2008; 142(1):137-8. DOI: 10.1111/j.1365-2141.2008.07157.x. View

Bignell G, Greenman C, Davies H, Butler A, Edkins S, Andrews J . Signatures of mutation and selection in the cancer genome. Nature. 2010; 463(7283):893-8. PMC: 3145113. DOI: 10.1038/nature08768. View

Andersson A, Eden P, Lindgren D, Nilsson J, Lassen C, Heldrup J . Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations. Leukemia. 2005; 19(6):1042-50. DOI: 10.1038/sj.leu.2403749. View

Sharma S, Haber D, Settleman J . Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer. 2010; 10(4):241-53. DOI: 10.1038/nrc2820. View

Neve R, Chin K, Fridlyand J, Yeh J, Baehner F, Fevr T . A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006; 10(6):515-27. PMC: 2730521. DOI: 10.1016/j.ccr.2006.10.008. View

SANFORD K, Earle W, LIKELY G . The growth in vitro of single isolated tissue cells. J Natl Cancer Inst. 1948; 9(3):229-46. View

Mire-Sluis A, PAGE L, Thorpe R . Quantitative cell line based bioassays for human cytokines. J Immunol Methods. 1995; 187(2):191-9. DOI: 10.1016/0022-1759(95)00220-1. View

10.

Nelson-Rees W, Flandermeyer R . HeLa cultures defined. Science. 1976; 191(4222):96-8. DOI: 10.1126/science.1246601. View

11.

Drexler H, Matsuo Y . Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia. 1999; 13(6):835-42. DOI: 10.1038/sj.leu.2401428. View

12.

PULVERTAFT J . CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA). Lancet. 1964; 1(7327):238-40. DOI: 10.1016/s0140-6736(64)92345-1. View

13.

MacLeod R, Drexler H . Public repositories: users reluctant to give materials. Nature. 2006; 439(7079):912. DOI: 10.1038/439912b. View

14.

Drexler H . Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 1998; 12(6):845-59. DOI: 10.1038/sj.leu.2401043. View

15.

Sandberg R, Ernberg I . Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci U S A. 2005; 102(6):2052-7. PMC: 548538. DOI: 10.1073/pnas.0408105102. View

16.

Sos M, Michel K, Zander T, Weiss J, Frommolt P, Peifer M . Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest. 2009; 119(6):1727-40. PMC: 2689116. DOI: 10.1172/JCI37127. View

17.

Rucker F, Sander S, Dohner K, Dohner H, Pollack J, Bullinger L . Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations. Leukemia. 2006; 20(6):994-1001. DOI: 10.1038/sj.leu.2404235. View

18.

Matsuo Y, Minowada J . Human leukemia cell lines--clinical and theoretical significances. Hum Cell. 1988; 1(3):263-74. View

19.

Osgood E, Brooke J . Continuous tissue culture of leukocytes from human leukemic bloods by application of gradient principles. Blood. 1955; 10(10):1010-22. View